Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies
出版年份 2018 全文链接
标题
Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-10-02
DOI
10.3389/fnagi.2018.00258
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
- (2018) Nikolaos Dagres et al. EUROPACE
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- (2018) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality
- (2018) Daniele Pastori et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2018) Zhi-Chun Gu et al. Frontiers in Pharmacology
- Does atrial fibrillation cause cognitive decline and dementia?
- (2017) Joanna Dietzel et al. EUROPACE
- Less dementia with oral anticoagulation in atrial fibrillation
- (2017) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Incidence and risk of respiratory tract infection associated with specific drug therapy in pulmonary arterial hypertension: a systematic review
- (2017) Zhichun Gu et al. Scientific Reports
- Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
- (2016) Victoria Jacobs et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice
- (2016) Robert J. Romanelli et al.
- Atrial Fibrillation and Mechanisms of Stroke
- (2016) Hooman Kamel et al. STROKE
- Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice
- (2016) Robert J. Romanelli et al. Circulation-Cardiovascular Quality and Outcomes
- Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta‐Analysis of 4894 Patients From 24 Randomized Double‐Blind Placebo‐Controlled Clinical Trials
- (2016) Anhua Wei et al. Journal of the American Heart Association
- Atrial fibrillation: A major risk factor for cognitive decline
- (2015) Dawn S. Hui et al. AMERICAN HEART JOURNAL
- Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia
- (2015) VICTORIA JACOBS et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Non-Vitamin K Antagonist Oral Anticoagulants Do Not Increase Cerebral Microbleeds
- (2015) Tsukasa Saito et al. Journal of Stroke & Cerebrovascular Diseases
- Atrial Fibrillation and Cognition
- (2015) Anna Poggesi et al. STROKE
- Non-Vitamin K Antagonist Oral Anticoagulants Do Not Increase Cerebral Microbleeds
- (2015) Tsukasa Saito et al. Journal of Stroke & Cerebrovascular Diseases
- Association Between Atrial Fibrillation and Dementia in the General Population
- (2015) Renée F. A. G. de Bruijn et al. JAMA Neurology
- Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia
- (2014) Victoria Jacobs et al. HEART RHYTHM
- Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
- (2014) Raffaele de Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Atrial fibrillation and cognitive decline: A longitudinal cohort study
- (2013) E. L. Thacker et al. NEUROLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies
- (2012) I. Marzona et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation
- (2010) Greg C. Flaker et al.
- Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia
- (2009) T. Jared Bunch et al. HEART RHYTHM
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started